Vnitr Lek 2008, 54(12):1161-1169

New evidence-based criteria for evaluating the appropriateness of drug regimen in seniors. Criteria STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment)

E. Topinková1,2,*, P. Mádlová1,2, D. Fialová1,3, J. Klán1,2
1 Geriatrická klinika 1. lékařské fakulty UK a VFN Praha, přednostka prof. MUDr. Eva Topinková, CSc.
2 Subkatedra geriatrie Institutu postgraduálního vzdělávání ve zdravotnictví Praha, přednostka prof. MUDr. Eva Topinková, CSc.
3 Katedra sociální a klinické farmacie Farmaceutické fakulty UK Hradec Králové, přednosta prof. RNDr. Jiří Vlček, CSc.

Drug prescribing in the old age is burdened by a significant number of prescribing errors often resulting in high rate of adverse drug events associated with increased morbidity, health care utilization and health costs. The revised 2003 Beers' Criteria represent the most widely used method for identification of high risk ("potentially inappropriate") medication in elderly persons. A standardized method for evaluating omission of potentially beneficial drugs has been lacking. The Beers' Criteria consist of the list of selected drugs with high potential of adverse drug events in old age and clinical conditions with relative contraindications of selected drugs (drug-disease interactions). Prescribing of these drugs should be avoided in older patients. However, several limitations prevent wider use of Beers' Criteria: several outdated drugs or drugs unavailable in Europe are listed, some controversial drugs with specific indications are on the list, drug-drug interaction and drug class duplications are not mentioned, and last but not least low user friendliness was criticized. To overcome these limitations, new STOPP and START Criteria were developed in 2007 to serve as a screening tool for comprehensive assessment of safety and quality of prescription in patients 65 years and older. In the current review article Czech version of both criteria are presented for the first time in the Czech literature. Using STOPP Criteria potentially inappropriate drugs are identified in drug regimen which could be stopped altogether or replaced by a safer drug alternative. Concomitant use of START Criteria will help the prescribing physician to consider the benefit of starting new drugs in selected clinical situations. Both screening tools represent a new method for improving quality of geriatric prescribing in clinical practice.

Keywords: evidence-based pharmacotherapy; elderly; STOPP and START criteria; appropriate drugs in old age

Received: September 10, 2008; Accepted: October 1, 2008; Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Topinková E, Mádlová P, Fialová D, Klán J. New evidence-based criteria for evaluating the appropriateness of drug regimen in seniors. Criteria STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Vnitr Lek. 2008;54(12):1161-1169.
Download citation

References

  1. Juurlink DN, Mamdami M, Kopp A et al. Drug-drug interactions among elderly patients hospitalised for drug toxicity. JAMA 2003; 289: 1652-1658. Go to original source... Go to PubMed...
  2. Goldberg RM, Mabee J, Chan L et al. Drug-drug and drug-disease interactions in the emergency department: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-450. Go to original source... Go to PubMed...
  3. Kriška M, Wawruch M. Dilema farmakoterapie v geriatrii. Problém polypragmazie a interakcií. Geriatria 2002; 8: 132-137.
  4. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2003; 57: 6-14. Go to original source... Go to PubMed...
  5. Fialová D, Topinková E. Specifické rysy geriatrické farmakoterapie z pohledu farmakokinetických a farmakodynamických změn ve stáří. Remedia 2002; 12: 434-440.
  6. Tinetti M. Preventing falls in elderly persons. New Engl J Med 2003; 348: 42-49. Go to original source... Go to PubMed...
  7. Hanlon JT, Horner RD, Schmader KE et al. Benzodiazepine use and cognitive function among community dwelling elderly. Clin Pharmacol Ther 1998; 64: 684-692. Go to original source... Go to PubMed...
  8. Gray SL, LaCroix AZ, Hanlon JT et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006; 54: 224-230. Go to original source... Go to PubMed...
  9. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs; a meta-analysis. Ann Intern Med 1991; 115: 787-796. Go to original source... Go to PubMed...
  10. Garcia Rodriguez LA, Hernandez-Diaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications. Systematic review of epidemiological studies. Br J Clin Pharmacol 2001; 52: 563-571. Go to original source... Go to PubMed...
  11. Sommer B, Fenn H, Pompei P et al. Safety of antidepressants in the elderly. Expert Opin Drug Saf 2003; 2: 367-383. Go to original source... Go to PubMed...
  12. Onder G, Pedone C, Landi F et al. Adverse drug reactions as a cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-1968. Go to original source... Go to PubMed...
  13. Topinková E, Fialová D. Geriatrická farmakoterapie - léčiva nevhodná pro starší nemocné. Postgrad Med 2006; 8 (mimořádná příloha): 28-35.
  14. Topinková E. Máme dostatek vědeckých důkazů pro farmakoterapii seniorů. Ageismus v klinických studiích. Postgrad Med 2008; 10: 571-585.
  15. Spinewine A, Schmader KE, Barber N et al. Appropriate prescribing in elderly people: how well can it be measured and optimized? Lancet 2007; 370: 173-184. Go to original source... Go to PubMed...
  16. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34: 338-346. Go to original source... Go to PubMed...
  17. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population based study of the very old. Drugs Aging 2005; 22: 69-82. Go to original source... Go to PubMed...
  18. Spinewine A, Swine C, Dhillon S et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomised, controlled trial. J Am Geriatr Soc 2007; 55: 658-665. Go to original source... Go to PubMed...
  19. Beers MH, Ouslander JG, Rollingher I et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-1832. Go to original source...
  20. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531-1536. Go to original source...
  21. Fick DM, Cooper JW, Wade W et al. Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults - Results of a US Consensus Panel of Experts. Arch Intern Med 2003; 163: 2716-2724. Go to original source... Go to PubMed...
  22. Naugler CT, Brymer C, Stolee P et al. Development and Validation of an Improved Prescribing for the Elderly Tool. Can J Clin Pharmacol 2000; 7: 103-107.
  23. Hanlon JT, Schmader KE, Sansa GP et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-1051. Go to original source... Go to PubMed...
  24. Fialová D, Topinková E. Koncept léčiv nevhodných ve stáří - farmakologické a farmakoepidemiologické aspekty. Remedia 2005; 15: 410-417.
  25. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34: 338-346. Go to original source... Go to PubMed...
  26. Fialova D, Topinkova E, Gambassi G et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348-1358. Go to original source... Go to PubMed...
  27. Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling elderly patients: a population based survey. Arch Intern Med 2002; 162: 1707-1712. Go to original source... Go to PubMed...
  28. van der Hooft CS, Jong GW, Dieleman JP et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria - a population based cohort study. Br J Clin Pharmacol 2005; 60: 2137-2144. Go to original source... Go to PubMed...
  29. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725-731. Go to original source... Go to PubMed...
  30. Vinšová J, Fialová D, Topinková E et al. Prevalence a vývojové trendy v preskripci léčiv potenciálně nevhodných ve stáří v České republice. Prakt Lék 2006; 86: 722-728.
  31. Wawruch M, Fialová S, Žikavská M et al. Používanie potencialne nevhodných liečiv pre starších pacientov v regione bývalého Česko-Slovenska. Klin Farmakol Farm 2008; 22: 108-112.
  32. Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999; 282: 113-115. Go to original source... Go to PubMed...
  33. O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008; 37: 138-141. Go to original source... Go to PubMed...
  34. Kunin CM. Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated? Arch Intern Med 2004; 164: 1701. Go to original source... Go to PubMed...
  35. Gallagher PF, Barry PJ, Ryan C et al. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing 2008; 37: 96-101. Go to original source... Go to PubMed...
  36. Oborne CA, Hooper R, Swift GG et al. Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 2003; 32: 102-108. Go to original source... Go to PubMed...
  37. Batty GM, Grant RL, Aggarwal R et al. Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing 2003; 32: 292-298. Go to original source... Go to PubMed...
  38. Shekelle PG, Maclean CH, Morton SC. ACOVE quality indicators. Ann Intern Med 2001; 135: 653-667. Go to original source... Go to PubMed...
  39. Gallagher P, Ryan C, Byrne S et al. STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment): Consensus Validation. Int J Clin Pharm Ther: 2008; 46: 72-83. Go to original source... Go to PubMed...
  40. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174. Go to original source... Go to PubMed...
  41. Topinková E et al. Nepublikované výsledky, 2008.
  42. Gallagher P, O'Mahony D STOPP (Screening Tool of Older People's potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing, in press.
  43. Barry P, Gallagher P, Ryan C et al. START Screening Tool to Alert Doctors to Right Treatment. An evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 628-631. Go to original source... Go to PubMed...
  44. Krska J, Cromarty JA, Arris F et al. Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care. Age Ageing 2001; 30: 205-211. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.